Cointime

Yuanyin Bio

company

About

Yuanyin Bio focuses on the research and application of circular RNA technology.

  • Haidian,Beijing,China
  • 51 - 100

Highlights

Total Funding Amount
¥380M
Funding Rounds
2
Investors
6

Details

Last Funding Type
Series A
Last Funding Money Raised
¥280M
Industries
Biopharma,Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2021
Number Of Employee
51 - 100
Operating Status
Active
Legal Name
Yuanyin (Beijing) Biotechnology Co., Ltd.
Also Known As
Therorna,Yuanyin Biotechnology

Yuanyin Bio is a biotechnology company focuses on the research and application of circular RNA technology in the field of innovative drugs and therapies, builds a robust pipeline of preventive and therapeutic new drugs, and is dedicated to addressing clinically unmet disease needs. They serve in the field of innovative drugs and therapies. It establishes a pipeline of preventive and therapeutic new drugs and is committed to solving clinically unmet disease needs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥380M
Yuanyin Bio has raised a total of ¥380M in funding over 2 rounds. Their latest funding was raised on Jun 20, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 20, 2022 Series A ¥280M 6 MSA Capital — Detail
Nov 29, 2021 Seed ¥100M 2 Quan Capital — Detail

Investors

Number of Lead Investors
Number of Investors
2
6
Yuanyin Bio is funded by 6 investors. MSA Capital and 3H Health Investment are the most recent investors.
Investor Name Lead Investor Funding Round
MSA Capital Yes Series A
3H Health Investment — Series A
Cenova — Series A
Quan Capital — Series A
Sherpa Venture Capital — Series A
Tencent — Series A
Cointime
Chủ Đề
Công Ty